Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with in Vivo Efficacy.
William McCoull,Scott Boyd,Martin R. Brown,Muireann Coen,Olga Collingwood,Nichola L. Davies,Ann Doherty,Gary Fairley,Kristin Goldberg,Elizabeth Hardaker, Guang He,Edward J. Hennessy,Philip Hopcroft,George Hodgson,Anne Jackson, Xiefeng Jiang,Ankur Karmokar, Anne-Laure Laine,Nicola Lindsay,Yumeng Mao,Roshini Markandu,Lindsay McMurray,Neville McLean,Lorraine Mooney,Helen Musgrove,J. Willem M. Nissink,Alexander Pflug,Venkatesh Pilla Reddy,Philip B. Rawlins,Emma Rivers,Marianne Schimpl,Graham F. Smith,Sharon Tentarelli,Jon Travers,Robert Troup,Josephine Walton, Cheng Wang, Stephen Wilkinson,Beth Williamson,Jon Winter-Holt,Dejian Yang, Yuting Zheng, Qianxiu Zhu,Paul D. Smith Journal of Medicinal Chemistry（2021）
AI 理解论文
溯源树
样例
